Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Rajeev K. Singla, Xiaoyan Wang, Rohit Gundamaraju, Shikha Joon, Christos Tsagkaris, Sahar Behzad, Johra Khan, Rupesh Gautam, Rajat Goyal, Jaruporn Rakmai, Ankit Kumar Dubey, Jesus Simal-Gandara & Bairong Shen. (2022) Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies. Critical Reviews in Food Science and Nutrition 0:0, pages 1-45.
Read now
Read now
Shaheenah Dawood. (2009) Pharmacology, Pharmacogenetics, and Pharmacoepidemiology: Three Ps of Individualized Therapy. Cancer Investigation 27:8, pages 809-815.
Read now
Read now
Neelima Denduluri & Sandra M Swain. (2008) Ixabepilone for the treatment of solid tumors: a review of clinical data. Expert Opinion on Investigational Drugs 17:3, pages 423-435.
Read now
Read now
Sharon Marsh & Howard L McLeod. (2007) Pharmacogenetics and oncology treatment for breast cancer. Expert Opinion on Pharmacotherapy 8:2, pages 119-127.
Read now
Read now
Michael C Cox, Tu D Dan & Sandra M Swain. (2006) Emerging drugs to replace current leaders in first-line therapy for breast cancer. Expert Opinion on Emerging Drugs 11:3, pages 489-501.
Read now
Read now
Articles from other publishers (36)
Hanaa R. M. Attia, Dina F. Ayoub, Shereen H. Abd El-Aziz, Mai M. Abdel Wahed, Safa N. Abd El-Fattah, Mahmoud A. Abdel-Monem, Thanaa M. Rabah, Mahmoud M. Kamel, Amany Helal & Mona Hamed Ibrahim. (2023) Down-regulation of MSH3 and MSH6 genes in female breast cancer patients receiving taxane-based therapy. Future Journal of Pharmaceutical Sciences 9:1.
Crossref
Crossref
Chunping Liu, Huiqi Chen, Sien Guo, Qiaojing Liu, Zhijun Chen, Haiding Huang, Qi Zhao, Longmei Li, Huan Cen, Zebo Jiang, Qiyuan Luo, Xiaoling Chen, Jiaxiong Zhao, Wensheng Chen, Phillip C. Yang & Lei Wang. (2023) Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions. Biomedicine & Pharmacotherapy 166, pages 115373.
Crossref
Crossref
Mayar Soussi, Alice Hasselsweiller & Dimitra Gkika. (2023) TRP Channels: The Neglected Culprits in Breast Cancer Chemotherapy Resistance?. Membranes 13:9, pages 788.
Crossref
Crossref
Nidhi Gupta, Hitesh Kumar, Sumeet Gupta, Basavarajaiah S. M. & Kamal Saini. (2023) A Concise Review on Natural Products and Their Derivatives for Breast Cancer Treatment. Chemistry & Biodiversity.
Crossref
Crossref
Aditya Mandapati & Kiven Erique Lukong. (2022) Triple negative breast cancer: approved treatment options and their mechanisms of action. Journal of Cancer Research and Clinical Oncology 149:7, pages 3701-3719.
Crossref
Crossref
Rajalakshmi Manikkam, Vijayalakshmi Periyasamy & Indu Sabapathy. 2023. Computational Methods in Drug Discovery and Repurposing for Cancer Therapy. Computational Methods in Drug Discovery and Repurposing for Cancer Therapy
201
222
.
Trishna Saha Detroja, Rajesh Detroja, Sumit Mukherjee & Abraham O. Samson. (2022) Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine. International Journal of Molecular Sciences 23:20, pages 12628.
Crossref
Crossref
Karishma Kailass, Oleg Sadovski, Warren R. Zipfel & Andrew A. Beharry. (2022) Two-Photon Photodynamic Therapy Targeting Cancers with Low Carboxylesterase 2 Activity Guided by Ratiometric Fluorescence. Journal of Medicinal Chemistry 65:13, pages 8855-8868.
Crossref
Crossref
Amir Khan, Ali Jan & Muhammad Qaiser Fatmi. 2022. Breast Cancer: From Bench to Personalized Medicine. Breast Cancer: From Bench to Personalized Medicine
265
279
.
Huixin Xu, Yue Li, Jianming Guo, Yuan Sui, Baihui Chen, Dalin Li & Jiakang Jiang. (2021) A Meta-Analysis of the Efficacy of Albumin Paclitaxel versus Docetaxel in the Treatment of Breast Cancer. Journal of Healthcare Engineering 2021, pages 1-8.
Crossref
Crossref
Anna Wawruszak, Lidia Borkiewicz, Estera Okon, Wirginia Kukula-Koch, Syeda Afshan & Marta Halasa. (2021) Vorinostat (SAHA) and Breast Cancer: An Overview. Cancers 13:18, pages 4700.
Crossref
Crossref
Anna Burguin, Caroline Diorio & Francine Durocher. (2021) Breast Cancer Treatments: Updates and New Challenges. Journal of Personalized Medicine 11:8, pages 808.
Crossref
Crossref
Shyambabu Chaurasiya & Yuman Fong. (2020) Viroimmunotherapy for breast cancer: promises, problems and future directions. Cancer Gene Therapy 28:7-8, pages 757-768.
Crossref
Crossref
Sadhna Aggarwal, Sumit Singh Verma, Sumit Aggarwal & Subash Chandra Gupta. (2021) Drug repurposing for breast cancer therapy: Old weapon for new battle. Seminars in Cancer Biology 68, pages 8-20.
Crossref
Crossref
Wenyan Hao, Zengjuan Zheng, Lin Zhu, Lulu Pang, Jinqiu Ma, Siqing Zhu, Lina Du & Yiguang Jin. (2021) 3D printing‐based drug-loaded implanted prosthesis to prevent breast cancer recurrence post‐conserving surgery. Asian Journal of Pharmaceutical Sciences 16:1, pages 86-96.
Crossref
Crossref
Suzana Aulic, Domenico Marson, Erik Laurini, Maurizio Fermeglia & Sabrina Pricl. 2020. Nanomedicines for Breast Cancer Theranostics. Nanomedicines for Breast Cancer Theranostics
371
404
.
Abdelrahman M. Elhusseiny, Nidhi Relhan & William E. Smiddy. (2019) Docetaxel-induced maculopathy possibly potentiated by concurrent hydroxychloroquine use. American Journal of Ophthalmology Case Reports 16, pages 100560.
Crossref
Crossref
Özlem YERSAL, Mehmet YİĞİT, Nezih MEYDAN & Sabri BARUTCA. (2019) Retrospective evaluation of breast cancer patients with five or more axillary lymph node involvement achieving 5-year overall survival. The European Research Journal 5:2, pages 268-273.
Crossref
Crossref
Duan Ni, Na Liu & Chunquan Sheng. 2019. Protein Allostery in Drug Discovery. Protein Allostery in Drug Discovery
313
334
.
Nidhi Sharma, Herschel S. Dhekne & Sabyasachi Senapati. 2019. Phytochemistry: An in-silico and in-vitro Update. Phytochemistry: An in-silico and in-vitro Update
133
160
.
Michael Jelínek, Kamila Balušíková, Petr Daniel, Vlasta Němcová-Fürstová, Palani Kirubakaran, Martin Jaček, Longfei Wei, Xin Wang, Jiří Vondrášek, Iwao Ojima & Jan Kovář. (2018) Substituents at the C3′ and C3′N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel. Toxicology and Applied Pharmacology 347, pages 79-91.
Crossref
Crossref
Thomas Chaillou, Ashley McPeek & Johanna T. Lanner. (2017) Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapy. Physiological Reports 5:11, pages e13261.
Crossref
Crossref
Aramita Saha & Subrata Chattopadhyay. (2013) Assessment of pulmonary toxicities in breast cancer patients undergoing treatment with anthracycline and taxane based chemotherapy and radiotherapy- a prospective study. International Journal of Cancer Therapy and Oncology 1:2.
Crossref
Crossref
A Galan Garcia, H Nedev, K Bijian, J Su, M A Alaoui-Jamali & H U Saragovi. (2012) Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs. Oncogene 32:20, pages 2527-2533.
Crossref
Crossref
Albert J. de Graaf, Inês I. Azevedo Próspero dos Santos, Ebel H.E. Pieters, Dirk T.S. Rijkers, Cornelus F. van Nostrum, Tina Vermonden, Robbert J. Kok, Wim E. Hennink & Enrico Mastrobattista. (2012) A micelle-shedding thermosensitive hydrogel as sustained release formulation. Journal of Controlled Release 162:3, pages 582-590.
Crossref
Crossref
Margarette Bryan, E. Dianne Pulte, Kathleen C. Toomey, Lillian Pliner, Anna C. Pavlick, Tracie Saunders & Robert Wieder. (2010) A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer. Investigational New Drugs 29:6, pages 1482-1487.
Crossref
Crossref
V. E. Gol’dberg, T. Yu. Khrichkova, V. A. Shatalova, N. O. Popova, E. S. Burshtein, M. Yu. Minakova, V. V. Zhdanov & A. M. Dygai. (2011) Reactions of Granulocytic Lineage of Hemopoiesis and Mechanisms of Their Development in Combined Treatment with Adriablastin and Taxotere. Bulletin of Experimental Biology and Medicine 150:6, pages 718-721.
Crossref
Crossref
Susanna B. Park, Cindy S.-Y. Lin, Arun V. Krishnan, Michael L. Friedlander, Craig R. Lewis & Matthew C. Kiernan. (2011) Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. Muscle & Nerve 43:3, pages 367-374.
Crossref
Crossref
H.A. AzimJr.Jr., L. Del Mastro, G. Scarfone & F.A. Peccatori. (2011) Treatment of breast cancer during pregnancy: Regimen selection, pregnancy monitoring and more …. The Breast 20:1, pages 1-6.
Crossref
Crossref
Nathalie Chabbert-Buffet, Catherine Uzan, Joseph Gligorov, Suzette Delaloge, Roman Rouzier & Serge Uzan. (2010) Pregnancy after breast cancer: A need for global patient care, starting before adjuvant therapy. Surgical Oncology 19:1, pages e47-e55.
Crossref
Crossref
James J. La Clair. (2010) Natural product mode of action (MOA) studies: a link between natural and synthetic worlds. Natural Product Reports 27:7, pages 969.
Crossref
Crossref
Paul A. Foster, Yaik T. Ho, Simon P. Newman, Philip G. Kasprzyk, Mathew P. Leese, Barry V. L. Potter, Michael J. Reed & Atul Purohit. (2007) 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique. Breast Cancer Research and Treatment 111:2, pages 251-260.
Crossref
Crossref
Patricia M. LoRusso, Suzanne F. Jones, Kevin M. Koch, Nikita Arya, Ronald A. Fleming, Jill Loftiss, Lini Pandite, Shirish Gadgeel, Barbara L. Weber & Howard A. BurrisIIIIII. (2008) Phase I and Pharmacokinetic Study of Lapatinib and Docetaxel in Patients With Advanced Cancer. Journal of Clinical Oncology 26:18, pages 3051-3056.
Crossref
Crossref
Rajeshwar P. Verma & Corwin Hansch. (2008) Taxane Analogues against Breast Cancer: A Quantitative Structure–Activity Relationship Study. ChemMedChem 3:4, pages 642-652.
Crossref
Crossref
M. Gordaliza. (2008) Natural products as leads to anticancer drugs. Clinical and Translational Oncology 9:12, pages 767-776.
Crossref
Crossref
Debra Patt, Michelle Gauthier & Sharon Giordano. (2016) Paclitaxel in Breast Cancer. Women's Health 2:1, pages 11-21.
Crossref
Crossref